Banco Bilbao Vizcaya Argentaria, S.A. Selecta Biosciences Inc Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 12, 2020	SELL	$2.18 - $2.84 $1.18 Million - $1.54 Million	-541,203 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.83 - $4.06 $990,401 - $2.2 Million	541,203 New	541,203 $1.54 Million

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.